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Synthesis and characterization of OZH04 and OZH05.
S2-S3 
SI
N-(1-Methoxy-2,2,6,6-tetramethylpiperidin-4-yl)acetamide (OZH05).
To a solution of 4-acetamido-2,2,6,6-tetramethylpiperidinyl-1-oxyl (1.0 g, 4.33 mmol) in acetone (20 mL) was added CuCl (20 mg, 0.12 mmol) followed by 50% H 2 O 2 (1.0 mL). The reaction mixture was stirred at rt overnight and then concentrated. The residue was diluted with CH 2 Cl 2 (20 mL), washed with brine (2 x 10 mL), dried over MgSO 4 and concentrated to afford OZH05 as a white solid (0.68 g, 64% Immunofluorescence co-localisation studies with P. falciparum rings (top row) and schizonts (bottom row) that were treated with 10 µg/mL OZ277 for 2 h. The blood smears were fixed with prechilled methanol (-20 °C; 100%) and blocked with 1% BSA in PBS for 1 h. Scale bar 2 µm.
The primary antibodies used were directly labelled OZH04-2/2 (Alexa 488, green signal) and 
